This study is completed in the United States, in France, in Canada, .... It is testing intranasal Esketamine for depression.
Depression, SuicidalityDrugFrom 18 Years to 64 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether Intranasal Esketamine may be useful for adults experiencing depression.
What would participation involve?
Participants may receive Intranasal Esketamine, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Argentina, in Austria, and in Belgium.
Who is it mainly for?
This study appears to be mainly for adults with depression.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateStarted: June 15, 2017
Recruitment status
Completed
Enrollment listed in the registry
230
Sponsor
Janssen Research & Development, LLC
Sponsor type
Other organization
Study type
Drug
Intervention type
Medication / drug, OTHER
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, France, Canada, ...
Age range
From 18 Years to 64 Years
Official registry ID
NCT03097133
Official title
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Argentina · 4 sites
Clínica Privada Banfield S.A
Banfield
Site status: Not listed — confirm with the team
Hospital Fleni
Ciudad de Buenos Aires
Site status: Not listed — confirm with the team
Sanatorio Prof. Leon S. Morra
Córdoba
Site status: Not listed — confirm with the team
Clinica Privada de Salud Mental Santa Teresa de Ávila
La Plata
Site status: Not listed — confirm with the team
Austria · 2 sites
Medical University Vienna MUV
Vienna
Site status: Not listed — confirm with the team
Klinikum Wels Grieskirchen
Wels
Site status: Not listed — confirm with the team
Belgium · 3 sites
AZ Sint Jan Brugge Oostende AV
Bruges
Site status: Not listed — confirm with the team
UZ Gent
Ghent
Site status: Not listed — confirm with the team
ARIADNE
Lede
Site status: Not listed — confirm with the team
Brazil · 6 sites
Universidade Federal De Minas Gerais - Hospital das Clínicas
Belo Horizonte
Site status: Not listed — confirm with the team
Universidade Federal Do Ceara
Fortaleza
Site status: Not listed — confirm with the team
Instituto Bairral de Psiquiatria
Itapira
Site status: Not listed — confirm with the team
Hospital Universitario Professor Edgar Santos
Salvador
Site status: Not listed — confirm with the team
CEMEC - Centro Multidisciplinar de Estudos Clínicos
Santo André
Site status: Not listed — confirm with the team
Hospital Das Clinicas Da Faculdade De Medicina Da USP
São Paulo
Site status: Not listed — confirm with the team
Canada · 2 sites
St. Michael's Hospital
Toronto, Ontario
Site status: Not listed — confirm with the team
Institut universitaire en sante mentale de Montreal
Montreal, Quebec
Site status: Not listed — confirm with the team
Czechia · 5 sites
Fakultni nemocnice Brno
Brno
Site status: Not listed — confirm with the team
Nemocnice s pol. Havirov, p.o.
Havířov
Site status: Not listed — confirm with the team
Narodni ustav dusevniho zdravi
Klecany
Site status: Not listed — confirm with the team
Vseobecna Fakultní Nemocnice
Prague
Site status: Not listed — confirm with the team
Ústrední vojenské nemocnice Praha
Prague
Site status: Not listed — confirm with the team
France · 6 sites
Hôpital de Bohars
Bohars
Site status: Not listed — confirm with the team
CHRU Montpellier Hopital Lapeyronie
Montpellier
Site status: Not listed — confirm with the team
CHU Caremeau
Nîmes
Site status: Not listed — confirm with the team
Hopital Sainte Anne
Paris
Site status: Not listed — confirm with the team
CHU Saint Etienne Hopital Nord
Saint-Priest-en-Jarez
Site status: Not listed — confirm with the team
CHU Toulouse
Toulouse
Site status: Not listed — confirm with the team
Lithuania · 3 sites
Hospital of Lithuanian University of Health Sciences Kaunas Clinics
Kaunas
Site status: Not listed — confirm with the team
Republic Kaunas Hospital
Kaunas County
Site status: Not listed — confirm with the team
Vilnius Mental Health Center
Vilnius
Site status: Not listed — confirm with the team
Poland · 4 sites
Uniwersyteckie Centrum Kliniczne
Gdansk
Site status: Not listed — confirm with the team
Szpital Specjalistyczny im H Klimontowicza Oddzial Psychiatryczny
Gorlice
Site status: Not listed — confirm with the team
SPZOZ CSK UM w Lodzi Klinika Zaburzen Afektywnych i Psychotycznych
Lodz
Site status: Not listed — confirm with the team
Klinika Psychiatryczna WUM Mazowieckie Specjalistyczne Centrum Zdrowia im prof Jana Mazurkiewicza
Pruszków
Site status: Not listed — confirm with the team
Spain · 4 sites
Hosp Univ Vall D Hebron
Barcelona
Site status: Not listed — confirm with the team
Inst. Internac. Neurociencias Aplicadas
Barcelona
Site status: Not listed — confirm with the team
Hosp. Univ. de Basurto
Bilbao
Site status: Not listed — confirm with the team
Clinica Univ. de Navarra
Pamplona
Site status: Not listed — confirm with the team
Türkiye · 4 sites
Bursa Sevket Yilmaz Research and Training Hospital
Bursa
Site status: Not listed — confirm with the team
Uludag University Medical Faculty
Bursa
Site status: Not listed — confirm with the team
Sisli Etfal Research Training Hospital
Istanbul
Site status: Not listed — confirm with the team
Samsun Psychiatric Hospital
Samsun
Site status: Not listed — confirm with the team
United States · 18 sites
University of California San Diego/Psychiatry
San Diego, California
Site status: Not listed — confirm with the team
Sharp Mesa Vista Hospital
San Diego, California
Site status: Not listed — confirm with the team
University of Conneticut School of Medicine
Farmington, Connecticut
Site status: Not listed — confirm with the team
University of Miami Health System
Miami, Florida
Site status: Not listed — confirm with the team
Innovative Clinical Research Inc
North Miami, Florida
Site status: Not listed — confirm with the team
University of South Florida
Tampa, Florida
Site status: Not listed — confirm with the team
Atlanta Behavioral Research, LLC
Atlanta, Georgia
Site status: Not listed — confirm with the team
Memorial Medical Center
Springfield, Illinois
Site status: Not listed — confirm with the team
Neuroscience Research Institute
Winfield, Illinois
Site status: Not listed — confirm with the team
Lake Charles Clinical Trials
Lake Charles, Louisiana
Site status: Not listed — confirm with the team
John Hopkins Hospital
Baltimore, Maryland
Site status: Not listed — confirm with the team
Altea Research Institute
Las Vegas, Nevada
Site status: Not listed — confirm with the team
The Zucker Hillside Hospital
Glen Oaks, New York
Site status: Not listed — confirm with the team
Stony Brook University Medical Center
Stony Brook, New York
Site status: Not listed — confirm with the team
University of North Carolina
Chapel Hill, North Carolina
Site status: Not listed — confirm with the team
University of Cincinnati, Dept of Psychiatry & Behavioral Neuroscience
Cincinnati, Ohio
Site status: Not listed — confirm with the team
East Tennessee State University
Johnson City, Tennessee
Site status: Not listed — confirm with the team
University of Wisconsin Medical Center
Madison, Wisconsin
Site status: Not listed — confirm with the team
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT03097133. We help you review the study, but cannot decide medical eligibility.
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Esketamine, Placebo, Standard of Care. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with depression; age range: From 18 Years to 64 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Janssen Research & Development, LLC, which appears to be another type of organization. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
